Xiaowei Deng1, Juan Yang1, Wei Wang1, Xiling Wang1, Jiaxin Zhou1, Zhiyuan Chen1, Jing Li1, Yinzi Chen1, Han Yan1, Juanjuan Zhang1, Yongli Zhang2, Yan Wang1, Qi Qiu1, Hui Gong1, Xianglin Wei1, Lili Wang1, Kaiyuan Sun3, Peng Wu4, Marco Ajelli5,6, Benjamin J Cowling4, Cecile Viboud3, Hongjie Yu1. 1. School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China. 2. Savaid Medical School, University of Chinese Academy of Sciences, Beijing, China. 3. Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, Maryland, USA. 4. WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong Special Administrative Region, China. 5. Bruno Kessler Foundation, Trento, Italy. 6. Department of Epidemiology and Biostatistics, Indiana University School of Public Health, Bloomington, Indiana, USA.
Abstract
BACKGROUND: To assess the case fatality risk (CFR) of COVID-19 in mainland China, stratified by region and clinical category, and estimate key time-to-event intervals. METHODS: We collected individual information and aggregated data on COVID-19 cases from publicly available official sources from 29 December 2019 to 17 April 2020. We accounted for right-censoring to estimate the CFR and explored the risk factors for mortality. We fitted Weibull, gamma, and log-normal distributions to time-to-event data using maximum-likelihood estimation. RESULTS: We analyzed 82 719 laboratory-confirmed cases reported in mainland China, including 4632 deaths and 77 029 discharges. The estimated CFR was 5.65% (95% confidence interval [CI], 5.50-5.81%) nationally, with the highest estimate in Wuhan (7.71%) and lowest in provinces outside Hubei (0.86%). The fatality risk among critical patients was 3.6 times that of all patients and 0.8-10.3-fold higher than that of mild-to-severe patients. Older age (odds ratio [OR], 1.14 per year; 95% CI, 1.11-1.16) and being male (OR, 1.83; 95% CI, 1.10-3.04) were risk factors for mortality. The times from symptom onset to first healthcare consultation, to laboratory confirmation, and to hospitalization were consistently longer for deceased patients than for those who recovered. CONCLUSIONS: Our CFR estimates based on laboratory-confirmed cases ascertained in mainland China suggest that COVID-19 is more severe than the 2009 H1N1 influenza pandemic in hospitalized patients, particularly in Wuhan. Our study provides a comprehensive picture of the severity of the first wave of the pandemic in China. Our estimates can help inform models and the global response to COVID-19.
BACKGROUND: To assess the case fatality risk (CFR) of COVID-19 in mainland China, stratified by region and clinical category, and estimate key time-to-event intervals. METHODS: We collected individual information and aggregated data on COVID-19 cases from publicly available official sources from 29 December 2019 to 17 April 2020. We accounted for right-censoring to estimate the CFR and explored the risk factors for mortality. We fitted Weibull, gamma, and log-normal distributions to time-to-event data using maximum-likelihood estimation. RESULTS: We analyzed 82 719 laboratory-confirmed cases reported in mainland China, including 4632 deaths and 77 029 discharges. The estimated CFR was 5.65% (95% confidence interval [CI], 5.50-5.81%) nationally, with the highest estimate in Wuhan (7.71%) and lowest in provinces outside Hubei (0.86%). The fatality risk among critical patients was 3.6 times that of all patients and 0.8-10.3-fold higher than that of mild-to-severe patients. Older age (odds ratio [OR], 1.14 per year; 95% CI, 1.11-1.16) and being male (OR, 1.83; 95% CI, 1.10-3.04) were risk factors for mortality. The times from symptom onset to first healthcare consultation, to laboratory confirmation, and to hospitalization were consistently longer for deceased patients than for those who recovered. CONCLUSIONS: Our CFR estimates based on laboratory-confirmed cases ascertained in mainland China suggest that COVID-19 is more severe than the 2009 H1N1 influenza pandemic in hospitalized patients, particularly in Wuhan. Our study provides a comprehensive picture of the severity of the first wave of the pandemic in China. Our estimates can help inform models and the global response to COVID-19.
Authors: Stefano Signoroni; Chiara Maura Ciniselli; Giovanni Apolone; Marco Vitellaro; Guglielmo Niccolò Piozzi; Maria Teresa Ricci; Marta Pastori; Paolo Merola; Marco Bellazzi; Tatiana Smaldone; Giuseppe Rosito; Claudia Borreani; Paolo Verderio Journal: Qual Life Res Date: 2021-08-23 Impact factor: 3.440
Authors: Chiara Becchetti; Marco Fabrizio Zambelli; Luisa Pasulo; Maria Francesca Donato; Federica Invernizzi; Olivier Detry; Géraldine Dahlqvist; Olga Ciccarelli; Maria Cristina Morelli; Montserrat Fraga; Gianluca Svegliati-Baroni; Hans van Vlierberghe; Minneke J Coenraad; Mario Cristobal Romero; Andrea de Gottardi; Pierluigi Toniutto; Luca Del Prete; Claudia Abbati; Didier Samuel; Jacques Pirenne; Frederik Nevens; Jean-François Dufour Journal: Gut Date: 2020-06-22 Impact factor: 23.059
Authors: Anita Balakrishnan; Mickael Lesurtel; Ajith K Siriwardena; Stefan Heinrich; Alejandro Serrablo; Marc G H Besselink; Mert Erkan; Bodil Andersson; Wojciech G Polak; Andrea Laurenzi; Stefan W M Olde Damink; Frederik Berrevoet; Isabella Frigerio; Jose M Ramia; Thomas K Gallagher; Susanne Warner; Shailesh V Shrikhande; Rene Adam; Martin D Smith; Kevin C Conlon Journal: HPB (Oxford) Date: 2020-06-10 Impact factor: 3.647
Authors: Han Fu; Haowei Wang; Xiaoyue Xi; Adhiratha Boonyasiri; Yuanrong Wang; Wes Hinsley; Keith J Fraser; Ruth McCabe; Daniela Olivera Mesa; Janetta Skarp; Alice Ledda; Tamsin Dewé; Amy Dighe; Peter Winskill; Sabine L van Elsland; Kylie E C Ainslie; Marc Baguelin; Samir Bhatt; Olivia Boyd; Nicholas F Brazeau; Lorenzo Cattarino; Giovanni Charles; Helen Coupland; Zulma M Cucunuba; Gina Cuomo-Dannenburg; Christl A Donnelly; Ilaria Dorigatti; Oliver D Eales; Richard G FitzJohn; Seth Flaxman; Katy A M Gaythorpe; Azra C Ghani; William D Green; Arran Hamlet; Katharina Hauck; David J Haw; Benjamin Jeffrey; Daniel J Laydon; John A Lees; Thomas Mellan; Swapnil Mishra; Gemma Nedjati-Gilani; Pierre Nouvellet; Lucy Okell; Kris V Parag; Manon Ragonnet-Cronin; Steven Riley; Nora Schmit; Hayley A Thompson; H Juliette T Unwin; Robert Verity; Michaela A C Vollmer; Erik Volz; Patrick G T Walker; Caroline E Walters; Oliver J Watson; Charles Whittaker; Lilith K Whittles; Natsuko Imai; Sangeeta Bhatia; Neil M Ferguson Journal: Int J Infect Dis Date: 2020-10-31 Impact factor: 3.623
Authors: Balbir B Singh; Michael P Ward; Mark Lowerison; Ryan T Lewinson; Isabelle A Vallerand; Rob Deardon; Jatinder P S Gill; Baljit Singh; Herman W Barkema Journal: One Health Date: 2021-06-25